Literature DB >> 16538519

Crotonaldehyde accumulates in glial cells of Alzheimer's disease brain.

Motoko Kawaguchi-Niida1, Noriyuki Shibata, Shunichi Morikawa, Koji Uchida, Tomoko Yamamoto, Tatsuo Sawada, Makio Kobayashi.   

Abstract

Several studies have documented the involvement of oxidative stress represented by lipid peroxidation in the pathogenesis of Alzheimer's disease (AD). To test whether the highly reactive carbonyl crotonaldehyde (CRA), generated during lipid peroxidation, is involved in AD, we performed an immunohistochemical analysis in AD and age-matched control hippocampi using a specific antibody against protein-bound CRA (P-CRA). In the AD cases, P-CRA immunoreactivity was preferentially localized in reactive astrocytes and microglia around senile plaques (SPs) and those present in the neuropil, while it was weakly detectable in neurons and neurofibrillary tangles. P-CRA immunoreactivity was also localized in all portions of diffuse SPs and the dystrophic neurites of neuritic and classical SPs, but was undetectable in amyloid cores. Age-matched controls showed P-CRA immunoreactivity only very weakly in neurons. In contrast to P-CRA, immunoreactivities for protein-bound acrolein and 4-hydroxy-2-nonenal were mainly localized to neurons and rarely seen in glial cells. Our results suggest that increased oxidative stress and CRA formation in glial cells is implicated in the disease processes of AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16538519     DOI: 10.1007/s00401-006-0044-1

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  9 in total

1.  Crotonaldehyde-induced vascular relaxation and toxicity: Role of endothelium and transient receptor potential ankyrin-1 (TRPA1).

Authors:  L Jin; G Jagatheesan; J Lynch; L Guo; D J Conklin
Journal:  Toxicol Appl Pharmacol       Date:  2020-04-19       Impact factor: 4.219

2.  Detecting reactive oxygen species by immunohistochemistry.

Authors:  Geou-Yarh Liou; Peter Storz
Journal:  Methods Mol Biol       Date:  2015

Review 3.  4-Hydroxynonenal in the pathogenesis and progression of human diseases.

Authors:  Mohammad Shoeb; Naseem H Ansari; Satish K Srivastava; Kota V Ramana
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

Review 4.  Molecular mechanisms of the conjugated alpha,beta-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases.

Authors:  Richard M LoPachin; David S Barber; Terrence Gavin
Journal:  Toxicol Sci       Date:  2007-12-13       Impact factor: 4.849

5.  Induction of heme oxygenase-1 inhibits cell death in crotonaldehyde-stimulated HepG2 cells via the PKC-δ-p38-Nrf2 pathway.

Authors:  Seung Eun Lee; Hana Yang; Seong Il Jeong; Young-Ho Jin; Cheung-Seog Park; Yong Seek Park
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

Review 6.  Role of lipid peroxidation-derived α, β-unsaturated aldehydes in vascular dysfunction.

Authors:  Seung Eun Lee; Yong Seek Park
Journal:  Oxid Med Cell Longev       Date:  2013-05-30       Impact factor: 6.543

7.  Beta-amyloid 25-35 peptide reduces the expression of glutamine transporter SAT1 in cultured cortical neurons.

Authors:  Doungjai Buntup; Oivind Skare; Tom Tallak Solbu; Farrukh A Chaudhry; Jon Storm-Mathisen; Wipawan Thangnipon
Journal:  Neurochem Res       Date:  2007-11-01       Impact factor: 3.996

8.  Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer's disease pathology.

Authors:  John H T Power; Sana Asad; Tim K Chataway; Fariba Chegini; James Manavis; James A Temlett; Poul H Jensen; Peter C Blumbergs; Wei-Ping Gai
Journal:  Acta Neuropathol       Date:  2008-04-02       Impact factor: 17.088

9.  Systematic review of human post-mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimer's disease.

Authors:  Lucía Viejo; Ayush Noori; Emily Merrill; Sudeshna Das; Bradley T Hyman; Alberto Serrano-Pozo
Journal:  Neuropathol Appl Neurobiol       Date:  2021-08-17       Impact factor: 6.250

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.